Noromectin Dewormer
Noromectin is an Ivermectin-based horse wormer in paste form. Killing both the larval and adult stages of small and large Redworms, Lungworms, and Bots. With each syringe treating a 700kg horse, Noromectin is a powerful and effective worming treatment, particularly useful on small Redworms which have a high Benzimidazole resistance.
Uses
Noromectin 1.87% Oral Paste for Horses kills the adult and some larval stages of the important internal parasites of horses.
Noromectin 1.87% Oral Paste for Horses at the recommended dose rate of 200mcg ivermectin per kg bodyweight is indicated for the treatment of the following internal parasites of horses:
Large strongyles (redworms): Adults and 4th larval (arterial) stages of Strongylus vulgaris, adults and tissue larval stages of S. edentatus and adults of S. equinus.
Adult small strongyles (redworms) including
benzimidazole resistant strains: Cyathostomum catinatum, Cyathostomum pateratum, Cylicocyclus ashworthi, Cylicocyclus elongatus, Cylicocyclus insigne, Cylicocyclus leptostomum, Cylicocyclus nassatus, Cylicocyclus radiatus, Cylicostephanus asymetricus, Cylicostephanus bidentatus, Cylicostephanus Calicatus, Cylicostephanus goldi, Cylicostephanus longibursatus, Cylicostephanus minutus, Cylicodontophorus bicornatus and Gyalocephalus capitatus.
Adult and immature lungworms: Dictyocaulus arnfieldi.
Pinworms: Adult and immature Oxyuris equi.
Ascarids: Adult and 3rd and 4th stage Parascaris equorum.
Hairworms: Adult Trichostrongylus axei.
Intestinal threadworms: Adult Strongyloides westeri.
Neck threadworms: Microfilariae of Onchocerca spp.
Oral and gastric larval stages of stomach bots: Gasterophilus spp.
Ivermectin is not effective against encysted larval stages of the
small strongyles.
Dosage & Administration
Noromectin 1.87% Oral Paste for Horses is administered orally at a single dose rate of 200mcg/kg of bodyweight. One syringe division of paste should be administered per 100kg bodyweight (based on the recommended dosage of 200mcg/kg). Each syringe delivers 140mg ivermectin, sufficient to treat 700kg of bodyweight. The tip of the syringe barrel should be inserted at the interdental space (the gap between the front and back teeth). The horse’s head should be raised for a few seconds after dosing.
Horses’ weight should be accurately determined for the correct use of the paste. The animal’s mouth should be free of food to ensure swallowing.
For best results all horses in a yard or grazing together should be included in a regular parasite control programme and treated at the same time.
All horses should be included in a regular parasite control programme, with particular attention being paid to mares, foals and yearlings. Foals should be treated initially at 6-8 weeks of age and routine treatment repeated as appropriate.
Retreatment should be carried out according to the epidemiological situation, but not less than at a 30 day interval.
Do not use the same syringe to treat more than one animal unless horses are running together or in direct contact with each other on the same premises.
As with all anthelmintics, a veterinary surgeon should establish appropriate dosing programmes and stock management to achieve adequate parasite control and reduce the likelihood of anthelmintic resistance developing.
Withdrawal Period
Animals must not be slaughtered for human consumption
during treatment.Horses must not be treated within 34 days of slaughter for human consumption. Do not use in mares producing milk for human consumption.
Contraindictions, Warnings etc
Mild transitory signs (slowed pupillary light response and depression) have been seen at a higher dose of 1.8mg/kg (9 times the recommended dose level). Other signs seen at higher doses include mydriasis, ataxia, tremors, stupor, comaand death. The less severe signs have been transitory. Although no antidote has been identified, symptomatic therapy may be beneficial.
Noromectin 1.87% Oral Paste for Horses has been formulated for use in horses only. Dogs and cats may be adversely affected by the concentration of ivermectin in the product if they are allowed to ingest spilled paste or have access to used syringes.
Do not smoke or eat while handling the product. Wash hands after use. Avoid eye contact. This is a unidose product which should be disposed of after use.
Frequent and repeated use may lead to the development of resistance.
Do not use in dogs or cats as severe adverse reactions may occur.
Some horses have experienced reactions involving cutaneous swelling and itching shortly after treatment. In most of these cases, the horses have been diagnosed as carrying heavy infections of Onchocerca microfilariae, and it is assumed the reactions are a result of the microfilariae dying in large numbers. Although the signs will resolve spontaneously in a few days, symptomatic treatment may be advisable. Consult your veterinary surgeon should these signs persist.
Horses of all ages, including young foals, pregnant mares and breeding stallions have been treated with no adverse effects on their health and fertility. Ivermectin passes readily into milk.
When administering to lactating females, residues of ivermectin could be present in the maternal milk. No studies have been reported on the effect of ingestion of milk on the development of newborn foals.
Composition
Substance/Preparation : Preparation.
Active Ingredients : 22, 23-Dihydroavermectin B1( Ivermectin ).
Description : Anthelmintic Endectocide ( Chemical Group 3-AV ).
Chemical Family : Avermectins.
